AZT.OL Live signals | Maximize Profits with Getagraph.com

BUY 20612 min ago

@ NOK28.60

Issued: 5 Apr 2024 @ 04:21

Return: -6.29%

Previous signal: Apr 4 - 08:10

Previous signal: Sell

Return: 0.00 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 10:25):

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing...

Stats
Today's Volume	15 692.00
Average Volume	34 710.00
Market Cap	1.36B
EPS	NOK0 ( 2024-01-31 )
Next earnings date	( NOK0.0700 ) 2024-05-07
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	78.82
ATR14	NOK0.246 (0.92%)

Arcticzymes Technologies Correlation

10 Most Positive Correlations
EQNR.OL	0.878
OTS.OL	0.855
CADLR.OL	0.847
XXL.OL	0.846
BEWI.OL	0.841
TOM.OL	0.839
MULTI.OL	0.819
VAR.OL	0.819
B2H.OL	0.818
NAVA.OL	0.815

10 Most Negative Correlations
ZAL.OL	-0.882
SIOFF.OL	-0.876
FROY.OL	-0.86
SOAG.OL	-0.859
PROT.OL	-0.852
VEI.OL	-0.85
ODL.OL	-0.837
SALM.OL	-0.833
SVEG.OL	-0.83
PGS.OL	-0.83

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arcticzymes Technologies Financials

Annual	2023
Revenue:	NOK118.94M
Gross Profit:	NOK47.77M (40.16 %)
EPS:	NOK0.370

Q4	2023
Revenue:	NOK28.38M
Gross Profit:	NOK9.35M (32.96 %)
EPS:	NOK0.0399

Q3	2023
Revenue:	NOK31.15M
Gross Profit:	NOK30.14M (96.74 %)
EPS:	NOK0.120

Q2	2023
Revenue:	NOK28.22M
Gross Profit:	NOK27.36M (96.95 %)
EPS:	NOK0.110

Financial Reports:

No articles found.

Arcticzymes Technologies

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.